- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06853691
The Effects of Glasses-Free 3D Training on Visual and Cognitive Function in Presbyopic Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Presbyopia is a manifestation of aging, and the prevalence of presbyopia increases with age. About 1.7 to 2 billion people in the world have presbyopia. According to the criteria proposed by Hofstetter in 1950, presbyopia symptoms begin to appear in different individuals from the age of 40, and complete presbyopia occurs at the age of 60. With the occurrence of presbyopia, there will be a series of accompanying diseases, such as the decrease of contrast sensitivity, leading to visual discomfort. Moreover, near work is difficult and even affects daily life.
Conventional ophthalmic analysis and intervention are sufficient. Although invasive correction methods can achieve satisfactory visual quality, there is a certain surgical risk. It is necessary to consider not only the patient's general condition, but also the follow-up care. Some monocular correction at the cost of binocular stereoscopic vision will cause the damage of depth perception and seriously affect stereoscopic vision. Non-invasive methods also have certain limitations, such as glasses correction will increase the risk of falls due to the surrounding jumping and swimming effects, the effect of drugs is temporary, and will cause a series of adverse reactions. The glasses-free 3D vision training equipment is simple to operate, easy to implement the training process, and the content is variable, and no other equipment is needed. Due to the popularity of video terminals, the prevalence of electronic device related asthenopia is also increasing. In order to explore the improvement of accommodation function and the relief of asthenopia after glasses-free 3D training, a randomized controlled trial was designed. The effects of this training on the central nervous system were analyzed by electroencephalogram (EEG) and near-infrared spectroscopy (fNIRS).
The aim of this study is to evaluate the improvement of visual function, application ability of visual function, and visual comfort in patients with presbyopia through the intervention of glasses-free 3D visual training, and to evaluate the functional changes of brain visual-related areas in patients with presbyopia before and after the training combined with EEG and NIRS. To explore the effects of stereoscopic stimulation on the functional connectivity of brain regions and different frequency bands. To explore the scientific nature and effectiveness of glasses-free 3D visual training in the rehabilitation of presbyopia, to provide a new theoretical basis and method for the clinical treatment of presbyopia, and to provide more information and clues for exploring the complex stereo vision imaging mechanism in the fields of brain science and ophthalmology.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yehong Zhuo, professor
- Phone Number: 020-66619349
- Email: zhuoyh@mail.sysu.edu.cn
Study Contact Backup
- Name: Jinan Zhan
- Phone Number: 15015072151
- Email: zhanjan@mail2.sysu.edu.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Zhongshan Opthalmic Center, Sun Yat-sen University
-
Contact:
- Yehong Zhuo, professor
- Phone Number: 020-66619349
- Email: zhuoyh@mail.sysu.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 40-60 years old, both sexes;
- refractive error -6.0D to 5.0D, astigmatism <2.0D, anisometropia <4.0D;
- binocular corrected visual acuity <0.2LogMAR;
- stereoscopic threshold ≤100 ';
- The subjects could understand the purpose of this study and sign the informed consent.
Exclusion Criteria:
- after lens replacement; People with cataracts, which affect vision, have other eye conditions such that simultaneous vision is not possible;
- using any medication known to affect accommodative function or wearing orthokeratology lenses in the past 1 month;
- patients with severe systemic disease or severe mental illness;
- Other situations where the investigator considers that the subject should not participate in the study for safety reasons or the interests of the patient.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Trail group
Conduct 15 minutes of naked-eye 3D vision training.
Twice a day, five days a week.
|
Trail group Conduct 15 minutes of naked-eye 3D vision training. Twice a day, five days a week. Control groups The subjects watched ordinary 2D videos for 15 minutes each time, all under the same lighting conditions. This was done twice a day, five days a week. |
|
No Intervention: Control groups
The subjects watched ordinary 2D videos for 15 minutes each time, all under the same lighting conditions.
This was done twice a day, five days a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amplitude of accommodation
Time Frame: Baseline and after 6 and 12 weeks of training
|
The push-up method combined with negative lens method was used.
The measurements were completed by a comprehensive refractometer.
It was performed according to the methods in Clinical Procedures for Ocular Examination 4th
|
Baseline and after 6 and 12 weeks of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Asthenopia scale
Time Frame: Baseline and after 6 and 12 weeks of training
|
The asthenopia scale consisted of 2 self-assessment items (" Do you have symptoms of asthenopia "and" does eye fatigue affect your study, work or life ") and 19 symptom items (" Do you feel discomfort around the eyes ")
|
Baseline and after 6 and 12 weeks of training
|
|
Vergence facility
Time Frame: Baseline and after 6 and 12 weeks of training
|
Vergence facility was tested using a lens flipper (3△BI/12△BO lens combination per eye) at 40cm with near correction
|
Baseline and after 6 and 12 weeks of training
|
|
Accommodative convergence to accommodation(AC/A)
Time Frame: Baseline and after 6 and 12 weeks of training
|
Accommodative response was measured by WAM-5500.
Additional accommodative and vergence stimuli were provided by spherical lenses
|
Baseline and after 6 and 12 weeks of training
|
|
The node efficiency
Time Frame: Baseline and after 6 and 12 weeks of training
|
Electroencephalogram (EEG) was performed to track the electrical activity of the brain in real-time, and the node efficiency was calculated. Node efficiency is a metric that characterizes the efficiency of a single node in connecting with all other parts of the network. It reflects the centrality and importance of a node within the network. |
Baseline and after 6 and 12 weeks of training
|
|
Hemodynamic response functions
Time Frame: Baseline and after 6 and 12 weeks of training
|
Functional near-infrared spectroscopy (fNIRS) was conducted to capture spatial information on cerebral blood flow and oxygenation conditions.
Therefore, a hemodynamic response function was constructed through it.
|
Baseline and after 6 and 12 weeks of training
|
|
Convergence accommodation to convergence(CA/C)
Time Frame: Baseline and after 6 and 12 weeks of training
|
Accommodative response was measured by WAM-5500,Additional accommodative and vergence stimuli were provided by prisms
|
Baseline and after 6 and 12 weeks of training
|
|
Functional connectivity network
Time Frame: Baseline and after 6 and 12 weeks of training
|
Electroencephalogram (EEG) was performed to track the electrical activity of the brain in real-time, and the functional connectivity network was calculated. Functional connectivity represent changes in brain activity in time domain and frequency domain respectively through correlation and coherence. |
Baseline and after 6 and 12 weeks of training
|
|
Negative relative vergence
Time Frame: Baseline and after 6 and 12 weeks of training
|
Negative relative vergence were measured by base in prism at 40cm with near correction
|
Baseline and after 6 and 12 weeks of training
|
|
Positive relative vergence
Time Frame: Baseline and after 6 and 12 weeks of training
|
Positive relative vergence were measured by base out prism at 40cm with near correction
|
Baseline and after 6 and 12 weeks of training
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accommodative facility
Time Frame: Baseline and after 6 and 12 weeks of training
|
Accommodative facility was tested using a lens flipper (+0.5D/-0.5 D lens combination) at 1m with distance correction
|
Baseline and after 6 and 12 weeks of training
|
|
Refraction and addition(near correction)
Time Frame: Baseline and after 6 and 12 weeks of training
|
In a semi-dark room, the Subjective Refraction and addition(ADD) measurements were performed.
Thus, the subjects' near correction prescription were obtained
|
Baseline and after 6 and 12 weeks of training
|
|
Near point of convergence
Time Frame: Baseline and after 6 and 12 weeks of training
|
Near point of convergence was measured using push-up method with near correction
|
Baseline and after 6 and 12 weeks of training
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024KYPJ113
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.